NEW YORK: Bristol-Myers Squibb (BMS) has prioritized employee communications as it proceeds after ousting CEO Peter Dolan on September 12.
Tony Plohoros, director of media relations at BMS, noted that chairman James Robinson sent around an e-mail to all staff reassuring them about the company's plans to move forward with all current ventures and the current patent litigation concerning Plavix.
BMS gave the news to the press immediately after the decision. Amid speculation that interim CEO James Cornelius is setting it up for acquisition, BMS told the media that it had "no comment."
While BMS has a longstanding relationship with Kekst & Company, Plohoros noted all communications were handled in-house.
Dolan's mishandling of the Plavix situation and a poor stock performance contributed to his exit, according to media reports. Plohoros said the search for a new CEO will include internal and external candidates, but no timeline has been determined.